Detalhe da pesquisa
1.
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.
Cancer
; 130(2): 287-299, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801052
2.
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
Ann Hematol
; 103(2): 427-436, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012435
3.
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
N Engl J Med
; 383(26): 2526-2537, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33369355
4.
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
N Engl J Med
; 382(2): 140-151, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914241
5.
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy.
Eur J Haematol
; 110(6): 696-705, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919878
6.
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study.
Ann Hematol
; 101(4): 855-867, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35128571
7.
Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature.
Acta Haematol
; 145(5): 566-570, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580565
8.
Philadelphia-Negative MPN: A Molecular Journey, from Hematopoietic Stem Cell to Clinical Features.
Medicina (Kaunas)
; 57(10)2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34684081
9.
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.
Haematologica
; 104(8): 1589-1596, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30819917
10.
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax.
Br J Haematol
; 203(4): e98-e101, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533098
11.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Am J Hematol
; 98(8): E204-E208, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222267
12.
Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.
Haematologica
; 102(3): 498-508, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27884971
13.
SARS-CoV-2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey.
Am J Hematol
; 97(7): E229-E232, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319125
14.
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.
Ann Hematol
; 93(8): 1391-400, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24705888
15.
Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis.
Cancers (Basel)
; 15(4)2023 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831347
16.
Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center Study.
Mediterr J Hematol Infect Dis
; 15(1): e2023022, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36908871
17.
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors.
Cancers (Basel)
; 15(13)2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444622
18.
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells.
Front Pharmacol
; 14: 1194712, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37305536
19.
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS).
J Clin Oncol
; 41(28): 4486-4496, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294914
20.
How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience.
Br J Haematol
; 176(4): 669-671, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26914729